Gsk (GLAXF) Pension (2009 - 2026)
Gsk (GLAXF) recorded quarterly Pension of -$2.3 billion in Q1 2026, down 1.83% quarter-over-quarter from -$2.2 billion in Q4 2025, and up 2.98% on a YoY basis from -$2.2 billion in Q1 2025.
Gsk (GLAXF) Pension (2009 - 2026) Analysis & Trends
Gsk's Pension history runs 18 years deep, the most recent figure standing at -$2.3 billion for Q1 2026.
- In Q1 2026, Pension rose 2.98% year-over-year to -$2.3 billion; the TTM figure through Mar 2026 stood at -$2.3 billion (up 2.98% YoY), while the FY2025 annual figure was -$2.2 billion, down 193.35% from the prior year.
- Pension was -$2.3 billion for Q1 2026 at Gsk, down from -$2.2 billion in the prior quarter.
- In the past five years, Pension ranged from a high of $3.0 billion in Q4 2022 to a low of -$3.5 billion in Q3 2022.
- Historically, Pension has averaged -$1.6 billion across 5 years, with a median of -$2.4 billion in 2025.
- The sharpest annual moves came in 2022 and 2023: Pension surged 92.82% in 2022, then sank 777.55% in 2023.
- A 5-year view of Pension shows it stood at $3.0 billion in 2022, then declined by 3.99% to $2.9 billion in 2023, then retreated by 17.62% to $2.4 billion in 2024, then tumbled by 193.79% to -$2.2 billion in 2025, then slipped by 1.83% to -$2.3 billion in 2026.
- The last three Pension figures came in at -$2.3 billion (Q1 2026), -$2.2 billion (Q4 2025), and -$2.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Gsk | - | - | 7.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.29 Bn |
| Dec 31, 2025 | -2.24 Bn |
| Sep 30, 2025 | -2.24 Bn |
| Jun 30, 2025 | -2.34 Bn |
| Mar 31, 2025 | -2.36 Bn |
| Dec 31, 2024 | 2.39 Bn |
| Sep 30, 2024 | -2.63 Bn |
| Jun 30, 2024 | -2.83 Bn |
| Mar 31, 2024 | -2.93 Bn |
| Dec 31, 2023 | 2.90 Bn |
| Sep 30, 2023 | -2.89 Bn |
| Jun 30, 2023 | -2.92 Bn |
| Mar 31, 2023 | -3.01 Bn |
| Dec 31, 2022 | 3.02 Bn |
| Sep 30, 2022 | -3.45 Bn |
| Jun 30, 2022 | -3.18 Bn |
| Mar 31, 2022 | -343.51 Mn |
| Dec 31, 2021 | 4.20 Bn |
| Sep 30, 2021 | -4.66 Bn |
| Jun 30, 2021 | -4.69 Bn |